Drug Trial Radar · NCT04634669
Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)
Last checked: Nov 19, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
181
Actual
Start
Sep 23, 2020
Primary completion
Feb 18, 2022
Study completion Mar 4, 2022
Sponsor
- Lead sponsor
- Axsome Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 18, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a multi-center, open-label trial to evaluate the long-term safety and efficacy of AXS-05 in subjects with major depressive disorder with prior treatment failures
Conditions
- Treatment Resistant Depression
- Major Depressive Disorder
Interventions
AXS-05 (dextromethorphan-bupropion)Drug
\- Titrated to AXS-05 (45 mg dextromethorphan HBr / 105 mg bupropion HCl) twice daily (up to 15 months)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-emergent AEs (TEAEs) Following Dosing With AXS-05Time frame: Duration of participation was up to 15 months. TEAEs were defined as any AE with an onset date in the interval between the first study treatment dosing date and 7 days after the last study treatment dosing date.
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Site
Little Rock, Arkansas
Clinical Research Site
Redlands, California
Clinical Research Site
Sherman Oaks, California
Clinical Research Site
Upland, California
Clinical Research Site
Miami, Florida
Clinical Research Site
Miami Lakes, Florida
Clinical Research Site
Orlando, Florida
Clinical Research Site
Chicago, Illinois
Clinical Research Site
Boston, Massachusetts
Clinical Research Site
Berlin, New Jersey
Clinical Research Site
Rochester, New York
Clinical Research Site
Staten Island, New York
Clinical Research Site
Hickory, North Carolina
Clinical Research Site
Raleigh, North Carolina
Clinical Research Site
Cincinnati, Ohio
Clinical Research Site
Middleburg Heights, Ohio
Clinical Research Site
Media, Pennsylvania
Clinical Research Site
Dallas, Texas
Clinical Research Site
Friendswood, Texas
Clinical Research Site
Everett, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.